Scientific understanding as the basis for individual cancer therapy

IndivuTest uses special methods for harvesting and processing cancer tissue to decode the individual cancer with the most modern technologies. These combine genetic analysis with protein measurements, the identification of cancer-related signaling pathways as well as other indicators for the behavior of the cancer. The individual picture created in this way enables the attending physician to select the presumably most effective drug based on scientific criteria. A database makes it possible to improve continuously the predictions of the drug effects and seek the newest active substances worldwide.

Indivumed was founded in 2002 in Hamburg to support the research and development of individualized cancer therapies with a research infrastructure that is unique throughout the world and a tumor tissue bank and database. Indivumed offers various services for the molecular analysis of biological sample materials and works on developing cancer markers for personalization of cancer therapy.